Development and validation of an RP-HPLC method for the simultaneous determination of Escitalopram Oxalate and Clonazepam in bulk and its pharmaceutical formulations

Authors

  • Chusena Narasimharaju Bhimanadhuni Research Scholar, Department of Pharmaceutical analysis, Prist University, Thanjavur, Tamilnadu
  • Devala Rao Garikapati Department of Pharmaceutical analysis, K.V.S.R Siddhartha College of Pharmaceutical Sciences, Vijayawada, Krishna (Dt), Andhra Pradesh
  • Pasupuleti Usha Department of Pharmaceutical analysis, Browns college of Pharmacy, Khammam, Andhra Pradesh

DOI:

https://doi.org/10.3329/icpj.v1i8.11249

Keywords:

Buffer, Acetonitrile, Escitalopram oxalate, Clonazepam, Tablets, Hypersil C18 column, RP-HPLC

Abstract

A Simple, efficient and reproducible reverse phase high performance liquid chromatographic method was developed and validated for the Simultaneous determination of Escitalopram oxalate and Clonazepam in combined dosage form. The separation was effected on a Hypersil ODS C18 column (250mm X 4.6mm; 5µ) using a mobile phase mixture of buffer and acetonitrile in a ratio of 50:50 v/v at a flow rate of 1.0ml/min. The detection was made at 240nm. The retention time of Escitalopram oxalate and Clonazepam was found to be 2.840± 0.007min and 4.007±0.006 min. Calibration curve was linear over the concentration range of 20-120µg/ml and 1-6µg/ml for Escitalopram oxalate and Clonazepam. All the analytical validation parameters were determined and found in the limit as per ICH guidelines, which indicates the validity of the method. The developed method is also found to be precise, accurate, specific, robust and rapid for the simultaneous determination of Escitalopram oxalate and Clonazepam in tablet dosage forms.

DOI: http://dx.doi.org/10.3329/icpj.v1i8.11249

International Current Pharmaceutical Journal 2012, 1(8): 193-198

 

Downloads

Download data is not yet available.
Abstract
471
PDF
157

Downloads

Published

2012-07-05

How to Cite

Bhimanadhuni, C. N., Garikapati, D. R., & Usha, P. (2012). Development and validation of an RP-HPLC method for the simultaneous determination of Escitalopram Oxalate and Clonazepam in bulk and its pharmaceutical formulations. International Current Pharmaceutical Journal, 1(8), 193–198. https://doi.org/10.3329/icpj.v1i8.11249

Issue

Vol. 1 No. 8 (2012)

Section

Original Articles

License

Authors who publish with this journal agree to the following terms:

  1. The journal holds copyright and publishes the work under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).